Clorox Q1 results beat estimates; expects FY adj EPS near low end of guidance range

By Reuters News


Overview

  • US consumer products maker's fiscal Q1 revenue rose 33%, beating analyst expectations

  • Adjusted EPS for fiscal Q1 rose 82% and beat consensus, driven by higher sales and cost savings

  • Company maintains full-year sales and adjusted EPS outlook, but sees results near low end of EPS range


Outlook

  • Clorox maintains FY 2027 net sales growth outlook of 13% to 14%

  • Company expects FY 2027 adjusted EPS between $5.70 and $6.00, near low end of range

  • Gross margin for FY 2027 now expected at about 41.5%, reflecting higher inflationary pressures


Result Drivers

  • GOJO ACQUISITION - Co said GOJO acquisition contributed about 15 points to net sales growth and 39 points to Health and Wellness segment growth

  • ERP TRANSITION LAP - Co said organic sales and adjusted EPS benefited from lapping prior-year ERP transition-related inventory drawdown

  • COST SAVINGS - Co delivered one of its strongest quarters of cost savings, helping offset higher commodity, manufacturing and logistics costs


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Revenue

Beat

$1.91 bln

$1.88 bln (12 Analysts)

Q1 Adjusted EPS

Beat

$1.55

$1.06 (15 Analysts)

Q1 EPS

$1.39

Q1 Gross Margin

40.40%


Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 16 "hold" and 3 "sell" or "strong sell"

  • The average consensus recommendation for the household products peer group is "buy."

  • Wall Street's median 12-month price target for The Clorox Company is $91.00, about 3.4% above its October 30 closing price of $88.00

  • The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 16 three months ago


Reuters Recommended Reads

  • Nov 2 - Estee Lauder beats Q1 adjusted EPS estimates, raises FY outlook

  • Nov 2 - Estee Lauder cuts promotions as luxury fragrances help lift outlook


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.